About Intigus Pharmaceutical Private Limited
Data last updated:
Intigus Pharmaceutical Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2019PTC113743. Its GSTIN is 09AAFCI1774D1ZM (Uttar Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Vishnu Kumar Singh and Sandeep Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1725 Pine Tower, Paramount Golf Foreste Surajpur Greater Noida, Uttar Pradesh, India – 201306.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.6 Cr, a growth of 81% compared to the previous year. For the same year it recorded a net profit of ₹41.02 Lakh (net margin 5.4%) and EBITDA of ₹62.73 Lakh (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years and 68% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Intigus Pharmaceutical. As per MCA filings, the company has open charges of ₹1.07 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website intiguspharma.com.
Company details
Contact details
Intigus Pharmaceutical Private Limited's registered office is in Noida, Uttar Pradesh. Its website is intiguspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1725 Pine Tower, Paramount Golf Foreste Surajpur Greater Noida, Uttar Pradesh, India – 201306
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Intigus Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Intigus Pharmaceutical operates one associated brand: Intigus Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical solutions for neurological, psychiatric, and pain management in India. | intiguspharma.com |
Business activity
The main business activity of Intigus Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Intigus Pharmaceutical Private Limited, buy the company report.
Financials of Intigus Pharmaceutical Private Limited
FY 2025 filings availableIntigus Pharmaceutical Private Limited reported revenue of ₹7.6 Cr (up 81% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 68% over five years, including 81% growth in the latest year. EBITDA rose 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹62.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Intigus Pharmaceutical Private Limited, buy the company report.
Board of directors of Intigus Pharmaceutical Private Limited
Intigus Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnu Kumar Singh | Director | 15 Feb 2019 | 7 Years 8 Months | Current |
| Sandeep Tiwari | Director | 03 Nov 2023 | 2 Years 11 Months | Current |
| Arti Singh | Director | 27 Jun 2024 | 2 Years 3 Months | Current |
Peer comparison
Intigus Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Silver Moon Motors Private Limited | ₹7.61 Cr (FY 2018) | -65.0% | Kangra, Himachal Pradesh, India | |||
| Sawariya Paper Private Limited | ₹7.61 Cr (FY 2025) | 9.0% | Delhi, India | |||
| Innoverts Network Private Limited | ₹7.61 Cr (FY 2024) | 1.0% | Bangalore, Karnataka, India | |||
| Radhegovind Apparel Private Limited | ₹7.6 Cr (FY 2024) | 54.0% | Patna, Bihar, India | |||
| Insightsmart Learning Private Limited | ₹7.6 Cr (FY 2025) | 11.0% | Rourkela, Odisha, India | |||
| Intigus Pharmaceutical Private Limitedthis company | ₹7.6 Cr (FY 2025) | ₹41.02 Lakh | 5.4% | 81.0% | Noida, Uttar Pradesh, India | |
| Arjan Global Private Limited | ₹7.6 Cr (FY 2024) | 16.0% | Delhi, India | |||
| Dharam Jewellers Private Limited | ₹7.6 Cr (FY 2024) | 2.0% | Raipur, Chhattisgarh, India | |||
| Sadhana Imitation Private Limited | ₹7.6 Cr (FY 2025) | 189269.0% | Rajkot, Gujarat, India | |||
| Swayamurja Renewable Energy Private Limited | ₹7.6 Cr (FY 2025) | 196.0% | Pune, Maharashtra, India | |||
| Shambhu Shree Services Private Limited | ₹7.6 Cr (FY 2020) | -39.0% | Delhi, India |
To see the full peer comparison of Intigus Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 May 2025 | 101094544 | Uco Bank | ₹8.37 Lakh | Open | |
| 01 Mar 2024 | 100874199 | Uco Bank | ₹9 Lakh | Open | |
| 23 Nov 2023 | 100852536 | Uco Bank | ₹90 Lakh | Open |
To see the full charge records of Intigus Pharmaceutical Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Intigus Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Intigus Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Intigus Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCI1774D1ZM | Uttar Pradesh | Active | 06 Mar 2019 |
To see the full GST registrations and return filing status of Intigus Pharmaceutical Private Limited, buy the company report.
Recent activity
Intigus Pharmaceutical Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Aakash Jaiswal ceased to be Director on 29 Jun 2024.
Frequently asked questions
Intigus Pharmaceutical is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 February 2019 (7+ years old) and is registered under CIN U51909UP2019PTC113743.
Intigus Pharmaceutical has 3 current directors:
- Vishnu Kumar Singh - Director
- Sandeep Tiwari - Director
- Arti Singh - Director
The latest financial statements of Intigus Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Intigus Pharmaceutical is 09AAFCI1774D1ZM, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Intigus Pharmaceutical is U51909UP2019PTC113743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Intigus Pharmaceutical was incorporated on 15 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Intigus Pharmaceutical by revenue are Silver Moon Motors Private Limited, Sawariya Paper Private Limited, Innoverts Network Private Limited, Radhegovind Apparel Private Limited, Insightsmart Learning Private Limited and 5 more, all in the same principal business activity (retail trading).
Aakash Jaiswal ceased to be Director on 29 Jun 2024. Bhupendra Ahuja ceased to be Director on 29 Jun 2024. Arti Singh was appointed as Director on 27 Jun 2024. Intigus Pharmaceutical has 5 board changes on record in total.
Intigus Pharmaceutical can be reached through the website intiguspharma.com. Its registered office is in Noida, Uttar Pradesh, India.
The registered office of Intigus Pharmaceutical is at 1725 Pine Tower, Paramount Golf Foreste Surajpur Greater Noida, Uttar Pradesh, India – 201306.
Intigus Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.